• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用定量 PCR 检测稳定期和加重期 COPD 气道细菌的患病率和负荷变化。

Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD.

机构信息

Centre for Respiratory Medicine, University College London, London, UK.

出版信息

Thorax. 2012 Dec;67(12):1075-80. doi: 10.1136/thoraxjnl-2012-201924. Epub 2012 Aug 3.

DOI:10.1136/thoraxjnl-2012-201924
PMID:22863758
Abstract

BACKGROUND

Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative.

METHODS

In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples.

RESULTS

Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV(1)%predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032).

CONCLUSIONS

Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used.

摘要

背景

先前已经使用微生物培养法研究了稳定期和加重期慢性阻塞性肺疾病(COPD)患者气道细菌的流行率和负荷。定量 PCR(qPCR)等分子技术可能更具信息量。

方法

本研究对 134 例 COPD 门诊患者的 373 份痰标本进行了多重 qPCR 检测,以评估典型气道细菌(流感嗜血杆菌、肺炎链球菌、卡他莫拉菌)的流行率和负荷,其中 176 份标本分析了非典型细菌。比较了 52 例患者稳定期和加重期的典型细菌数据。我们在 177/373 份标本中比较了常规培养和 qPCR。

结果

在稳定期和加重期配对样本中,典型细菌在加重期的流行率高于稳定期:30/52(57.7%)比 14/52(26.9%);p=0.001。在两个时间点均为细菌阳性的患者中,加重期的平均(±1 SEM)负荷明显高于稳定期,分别为 108.5(±0.3)cfu/ml 和 107.2(±0.5)cfu/ml),构成 20 倍的增加(p=0.011)。qPCR 比微生物培养法更能检测出典型细菌(流行率 59.3%比 24.3%;p<0.001)。在稳定期,气道细菌负荷越高,气流受限越严重(FEV1%predicted)(r=-0.299;p=0.033),吸入皮质激素剂量越高(r=0.382;p=0.008)。与细菌相关的加重期患者的 C 反应蛋白平均值较高(35.0 比 25.1 mg/L;p=0.032)。

结论

COPD 加重期气道细菌的流行率和负荷增加,是一种病因。qPCR 比培养法更具鉴别力,可识别更高的气道细菌流行率。与细菌检测相关的加重期患者的平均 C 反应蛋白水平较高。在稳定期,气道细菌负荷与更严重的气流受限和更高的吸入皮质激素剂量有关。

相似文献

1
Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD.使用定量 PCR 检测稳定期和加重期 COPD 气道细菌的患病率和负荷变化。
Thorax. 2012 Dec;67(12):1075-80. doi: 10.1136/thoraxjnl-2012-201924. Epub 2012 Aug 3.
2
Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease.稳定期慢性阻塞性肺疾病的炎症阈值及定植细菌的种属特异性效应
Respir Res. 2014 Sep 14;15(1):114. doi: 10.1186/s12931-014-0114-1.
3
Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.使用定量聚合酶链反应检测到的病原体与慢性阻塞性肺疾病稳定期气道炎症及急性加重之间的关联。
Chest. 2015 Jan;147(1):46-55. doi: 10.1378/chest.14-0764.
4
Sputum sample positivity for Haemophilus influenzae or Moraxella catarrhalis in acute exacerbations of chronic obstructive pulmonary disease: evaluation of association with positivity at earlier stable disease timepoints.慢性阻塞性肺疾病急性加重期流感嗜血杆菌或卡他莫拉菌的痰标本阳性:与稳定期早期阳性结果的相关性评估。
Respir Res. 2021 Feb 24;22(1):67. doi: 10.1186/s12931-021-01653-8.
5
Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.通过定量聚合酶链反应和培养法测定稳定期慢性阻塞性肺疾病患者气道细菌:与中性粒细胞性气道炎症、急性加重频率及肺功能的关系
Int J Chron Obstruct Pulmon Dis. 2015 Jun 9;10:1075-83. doi: 10.2147/COPD.S80091. eCollection 2015.
6
Lower Airway Bacterial Colonization Patterns and Species-Specific Interactions in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病下呼吸道细菌定植模式和种间特异性相互作用。
J Clin Microbiol. 2018 Sep 25;56(10). doi: 10.1128/JCM.00330-18. Print 2018 Oct.
7
Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease.气道细菌浓度与慢性阻塞性肺疾病的急性加重
Am J Respir Crit Care Med. 2007 Aug 15;176(4):356-61. doi: 10.1164/rccm.200703-417OC. Epub 2007 May 3.
8
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.细菌定植与慢性阻塞性肺疾病(COPD)急性加重的频率、特征及严重程度之间的关系。
Thorax. 2002 Sep;57(9):759-64. doi: 10.1136/thorax.57.9.759.
9
COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species.慢性阻塞性肺疾病的特征是流感嗜血杆菌、肺炎链球菌检测率增加,以及芽孢杆菌属缺乏。
Respirology. 2016 May;21(4):697-704. doi: 10.1111/resp.12734. Epub 2016 Jan 18.
10
Human rhinovirus infection during naturally occurring COPD exacerbations.人鼻病毒感染在自然发生的 COPD 加重期。
Eur Respir J. 2014 Jul;44(1):87-96. doi: 10.1183/09031936.00223113. Epub 2014 Mar 13.

引用本文的文献

1
Association between inhaled corticosteroids and incidence of idiopathic pulmonary fibrosis: nationwide population-based study.吸入性糖皮质激素与特发性肺纤维化发病率之间的关联:基于全国人群的研究。
BMJ Open Respir Res. 2025 May 22;12(1):e002566. doi: 10.1136/bmjresp-2024-002566.
2
Diagnosis and management of comorbid disease in COPD.慢性阻塞性肺疾病(COPD)合并症的诊断与管理
Breathe (Sheff). 2025 Feb 25;21(1):240099. doi: 10.1183/20734735.0099-2024. eCollection 2025 Jan.
3
Exploring the Role of Gut-Lung Interactions in COPD Pathogenesis: A Comprehensive Review on Microbiota Characteristics and Inflammation Modulation.
探讨肠道-肺相互作用在慢性阻塞性肺疾病发病机制中的作用:关于微生物群特征和炎症调节的综合综述
Chronic Obstr Pulm Dis. 2024 May 29;11(3):311-325. doi: 10.15326/jcopdf.2023.0442.
4
Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype.痰液微生物群的α多样性是慢性阻塞性肺疾病频繁急性加重表型的一个关键特征。
ERJ Open Res. 2024 Feb 5;10(1). doi: 10.1183/23120541.00595-2023. eCollection 2024 Jan.
5
Sputum microbiota and inflammatory subtypes in asthma, COPD, and its overlap.哮喘、慢性阻塞性肺疾病及其重叠综合征中的痰液微生物群和炎症亚型
J Allergy Clin Immunol Glob. 2023 Nov 21;3(1):100194. doi: 10.1016/j.jacig.2023.100194. eCollection 2024 Feb.
6
How inhaled corticosteroids target inflammation in COPD.吸入性皮质类固醇如何靶向 COPD 中的炎症。
Eur Respir Rev. 2023 Oct 18;32(170). doi: 10.1183/16000617.0084-2023. Print 2023 Dec 31.
7
Interactions between the lung microbiome and host immunity in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中肺微生物群与宿主免疫之间的相互作用。
Chronic Dis Transl Med. 2023 Apr 3;9(2):104-121. doi: 10.1002/cdt3.66. eCollection 2023 Jun.
8
Impact of prophylactic and 'rescue pack' antibiotics on the airway microbiome in chronic lung disease.预防性和“救援包”抗生素对慢性肺病患者气道微生物组的影响。
BMJ Open Respir Res. 2023 Apr;10(1). doi: 10.1136/bmjresp-2022-001335.
9
Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America.在慢性阻塞性肺疾病中,实时荧光定量聚合酶链反应(Real-time PCR)在鉴定主要气道细菌病原体方面优于基于培养的方法:欧洲和北美的三项临床研究结果
Front Microbiol. 2023 Feb 24;13:1098133. doi: 10.3389/fmicb.2022.1098133. eCollection 2022.
10
Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment.人类呼吸道微生物群落的分子核算与剖析:通过靶向呼吸微生物组进行疾病诊断和治疗,实现精准医学。
Int J Mol Sci. 2023 Feb 17;24(4):4086. doi: 10.3390/ijms24044086.